
Viemed Healthcare, Inc.: shareholders and insiders
Price
$8.78
November 18, 2026Market cap $339M
What Ploutos Investor adds for Viemed Healthcare
Part of Ploutos Investor, €9.99 a month
- The full history: 8 fiscal years, from 2018
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 18, 2025 to Aug 19, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$1.6M
3 people
From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 18, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $1.6M by 3 people
- 2025: no buys, no sales
- 2026: no buys, sold $1.6M by 3 people
- Aug 19, 2026Nitin KaushalDirectorKind
- Aug 19, 2026Sabrina HeltzDirectorKind
- Aug 19, 2026Sabrina HeltzDirectorKind
- Aug 19, 2026Sabrina HeltzDirectorKind
- Aug 19, 2026Randy E. DobbsDirectorKind
- Aug 19, 2026Randy E. DobbsDirectorKind
- Aug 19, 2026Randy E. DobbsDirectorKind
- Aug 19, 2026Timothy SmokoffDirectorKind
- Aug 19, 2026Timothy SmokoffDirectorKind
- Aug 19, 2026Timothy SmokoffDirectorKind
- Jun 25, 2026William FrazierChief Medical OfficerKind
- Jun 25, 2026William FrazierChief Medical OfficerKind
- Jun 24, 2026Timothy SmokoffDirectorKind
- Jun 24, 2026Timothy SmokoffDirectorKind
- Jun 24, 2026Timothy SmokoffDirectorKind
- Jun 24, 2026Timothy SmokoffDirectorKind
- Jun 24, 2026Timothy SmokoffDirectorKind
- Mar 20, 2026Michael MoorePresidentKind
- Mar 19, 2026Michael MoorePresidentKind
- Mar 18, 2026Michael MoorePresidentKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Nitin KaushalDirector | 18.8K | – | – | Form 4 | |
| Aug 19, 2026 | Sabrina HeltzDirector | 15.0K | – | – | Form 4 | |
| Aug 19, 2026 | Sabrina HeltzDirector | 3,757 | – | – | Form 4 | |
| Aug 19, 2026 | Sabrina HeltzDirector | 3,757 | $8.94 | $33.6K | Form 4 | |
| Aug 19, 2026 | Randy E. DobbsDirector | 16.8K | – | – | Form 4 | |
| Aug 19, 2026 | Randy E. DobbsDirector | 4,191 | – | – | Form 4 | |
| Aug 19, 2026 | Randy E. DobbsDirector | 4,191 | $8.94 | $37.5K | Form 4 | |
| Aug 19, 2026 | Timothy SmokoffDirector | 15.0K | – | – | Form 4 | |
| Aug 19, 2026 | Timothy SmokoffDirector | 3,757 | – | – | Form 4 | |
| Aug 19, 2026 | Timothy SmokoffDirector | 3,757 | $8.94 | $33.6K | Form 4 | |
| Jun 25, 2026 | William FrazierChief Medical Officer | 10.0K | $1.81 | $18.1K | Form 4 | |
| Jun 25, 2026 | William FrazierChief Medical Officer | 10.0K | $11.72 | $117.2K | Form 4 | |
| Jun 24, 2026 | Timothy SmokoffDirector | 1,636 | $11.48 | $18.8K | Form 4 | |
| Jun 24, 2026 | Timothy SmokoffDirector | 3,364 | $11.50 | $38.7K | Form 4 | |
| Jun 24, 2026 | Timothy SmokoffDirector | 5,000 | $11.56 | $57.8K | Form 4 | |
| Jun 24, 2026 | Timothy SmokoffDirector | 5,000 | $11.53 | $57.7K | Form 4 | |
| Jun 24, 2026 | Timothy SmokoffDirector | 5,000 | $11.41 | $57.1K | Form 4 | |
| Mar 20, 2026 | Michael MoorePresident | 65.0K | $8.77 | $570.1K | Form 4 | |
| Mar 19, 2026 | Michael MoorePresident | 40.2K | $9.21 | $370.5K | Form 4 | |
| Mar 18, 2026 | Michael MoorePresident | 31.6K | $9.42 | $297.4K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 26, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by VMD's officers and directors from 2022 up to November 17, 2025, 4 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Thrivent Financial for LutheransShare of class6.80%
- BlackRock Portfolio Management LLCShare of class6.40%
- Michael Moorewith 1 more personCommon Shares, No Par ValueShare of class5.90%
- BlackRock, Inc.Share of class5.80%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Thrivent Financial for Lutherans | 6.80% | 2.71M | Apr 29, 20252 filings since Nov 13, 2024 | 13G/A | |
| BlackRock Portfolio Management LLC | 6.40% | 2.54M | Jul 15, 2025 | 13G | |
| Michael Moorewith 1 more personCommon Shares, No Par Value | 5.90% | 2.29M | Sep 24, 2026 | 13D/A | |
| BlackRock, Inc. | 5.80% | 2.28M | Apr 23, 2025 | 13G/A |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
Michael Moore5.9%From the filing of Sep 24, 2026
Item 4 of the Schedule 13D is hereby amended and restated in its entirety as follows: Each of the Reporting Persons holds the Common Shares as reported herein for investment purposes and does not have any specific plans or proposals regarding the Issuer in such Reporting Person's capacity as a holder of Common Shares. Except as set forth below, each of the Reporting Persons does not have any current plans or proposals which relate to, or may result in, any of the matters listed in Items 4(a)-(j) of Schedule 13D. On September 24, 2026, MF LLC entered into a trading plan with Morgan Stanley Smith Barney LLC (the "Trading Plan") intended to satisfy the affirmative defense conditions of Rule…
From the filing of Sep 24, 2026
Fell to 5% or less (2)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Renaissance TechnologiesIn the quarter+9.4%
- Point72 (Cohen)In the quarter-14%
- Citadel Advisors (Griffin)In the quarter-32%
- Millennium Mgmt (Englander)In the quarter+424%
- AQR CapitalIn the quarter+91%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Renaissance Technologies | 466.0K | +9.4% | $4.2M | 0.01% |
| Point72 (Cohen) | 134.5K | -14% | $1.2M | 0.00% |
| Citadel Advisors (Griffin) | 158.4K | -32% | $1.4M | 0.00% |
| Millennium Mgmt (Englander) | 272.1K | +424% | $2.5M | 0.00% |
| AQR Capital | 393.2K | +91% | $3.6M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 3.98% of its shares outstanding were held short, -2.2% since the report before.
- Shares held short
- 1.54M
- 3.98%
- Since the report before1.57M on Sep 30, 2026
- -2.2%
- 6.4
- 239.8K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 74%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 317.7K
- Nov 15, 2023: Shares held short 253.2K
- Nov 30, 2023: Shares held short 330.8K
- Dec 15, 2023: Shares held short 250.8K
- Dec 29, 2023: Shares held short 197.2K
- Jan 12, 2024: Shares held short 179.6K
- Jan 31, 2024: Shares held short 167.7K
- Feb 15, 2024: Shares held short 168.9K
- Feb 29, 2024: Shares held short 178.2K
- Mar 15, 2024: Shares held short 202.5K
- Mar 28, 2024: Shares held short 406.2K
- Apr 15, 2024: Shares held short 396.7K
- Apr 30, 2024: Shares held short 437.8K
- May 15, 2024: Shares held short 430.3K
- May 31, 2024: Shares held short 312.8K
- Jun 14, 2024: Shares held short 273.6K
- Jun 28, 2024: Shares held short 296.8K
- Jul 15, 2024: Shares held short 297.7K
- Jul 31, 2024: Shares held short 283.4K
- Aug 15, 2024: Shares held short 254.3K
- Aug 30, 2024: Shares held short 287.8K
- Sep 13, 2024: Shares held short 279.9K
- Sep 30, 2024: Shares held short 205.5K
- Oct 15, 2024: Shares held short 305.1K
- Oct 31, 2024: Shares held short 361.2K
- Nov 15, 2024: Shares held short 291.2K
- Nov 29, 2024: Shares held short 284.8K
- Dec 13, 2024: Shares held short 309.2K
- Dec 31, 2024: Shares held short 344.4K
- Jan 15, 2025: Shares held short 365.1K
- Jan 31, 2025: Shares held short 303.8K
- Feb 14, 2025: Shares held short 298.4K
- Feb 28, 2025: Shares held short 287.9K
- Mar 14, 2025: Shares held short 318.1K
- Mar 31, 2025: Shares held short 398.2K
- Apr 15, 2025: Shares held short 339.9K
- Apr 30, 2025: Shares held short 319.2K
- May 15, 2025: Shares held short 336.8K
- May 30, 2025: Shares held short 326.1K
- Jun 13, 2025: Shares held short 391.7K
- Jun 30, 2025: Shares held short 384.2K
- Jul 15, 2025: Shares held short 405.8K
- Jul 31, 2025: Shares held short 476.2K
- Aug 15, 2025: Shares held short 422.9K
- Aug 29, 2025: Shares held short 418.6K
- Sep 15, 2025: Shares held short 461.4K
- Sep 30, 2025: Shares held short 402.9K
- Oct 15, 2025: Shares held short 384.2K
- Oct 31, 2025: Shares held short 394.5K
- Nov 14, 2025: Shares held short 406.1K
- Nov 28, 2025: Shares held short 393.5K
- Dec 15, 2025: Shares held short 386.8K
- Dec 31, 2025: Shares held short 325.4K
- Jan 15, 2026: Shares held short 358.2K
- Jan 30, 2026: Shares held short 371.2K
- Feb 13, 2026: Shares held short 354.7K
- Feb 27, 2026: Shares held short 347.6K
- Mar 13, 2026: Shares held short 450.1K
- Mar 31, 2026: Shares held short 390.7K
- Apr 15, 2026: Shares held short 351.5K
- Apr 30, 2026: Shares held short 447.1K
- May 15, 2026: Shares held short 408.6K
- May 29, 2026: Shares held short 502.8K
- Jun 15, 2026: Shares held short 464.6K
- Jun 30, 2026: Shares held short 519.1K
- Jul 15, 2026: Shares held short 747.1K
- Jul 31, 2026: Shares held short 671.7K
- Aug 14, 2026: Shares held short 787.1K
- Aug 31, 2026: Shares held short 1.21M
- Sep 15, 2026: Shares held short 1.32M
- Sep 30, 2026: Shares held short 1.57M
- Oct 15, 2026: Shares held short 1.54M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading42.0% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 42.0% of the shares in the reported trades were short sales, against 54.9% in the 14 before.
- Last 14 sessionsOct 29, 2026 – Nov 17, 2026
- 42.0%
- The 14 beforeOct 9, 2026 – Oct 28, 2026
- 54.9%
- Change
- -12.9 pts
- Short sales a dayon average, of 100.0K shares
- 42.1K
- More than atof 3,659 US-listed companies, same days
- 25%
- Median of alleight in ten from 34.6% to 63.7%
- 50.3%
- Short sales
- Oct 9, 2026: Short sales 52.3%
- Oct 12, 2026: Short sales 43.6%
- Oct 13, 2026: Short sales 52.3%
- Oct 14, 2026: Short sales 62.4%
- Oct 15, 2026: Short sales 44.1%
- Oct 16, 2026: Short sales 38.4%
- Oct 19, 2026: Short sales 51.1%
- Oct 20, 2026: Short sales 66.4%
- Oct 21, 2026: Short sales 65%
- Oct 22, 2026: Short sales 65.9%
- Oct 23, 2026: Short sales 79%
- Oct 26, 2026: Short sales 44.3%
- Oct 27, 2026: Short sales 52%
- Oct 28, 2026: Short sales 63.5%
- Oct 29, 2026: Short sales 37.8%
- Oct 30, 2026: Short sales 36.5%
- Nov 2, 2026: Short sales 40.5%
- Nov 3, 2026: Short sales 32.5%
- Nov 4, 2026: Short sales 41.6%
- Nov 5, 2026: Short sales 57.1%
- Nov 6, 2026: Short sales 51.9%
- Nov 9, 2026: Short sales 52.6%
- Nov 10, 2026: Short sales 42.1%
- Nov 11, 2026: Short sales 34.3%
- Nov 12, 2026: Short sales 38.8%
- Nov 13, 2026: Short sales 35.1%
- Nov 16, 2026: Short sales 19%
- Nov 17, 2026: Short sales 30.5%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Michael MoorePresidentDirectly126.3K
- Nitin KaushalDirectorDirectly161.4K
- Randy E. DobbsDirectorDirectly142.3K
- Timothy SmokoffDirectorDirectly90.5K
- Jerome CambreVice President of SalesDirectly87.5K
- Sabrina HeltzDirectorDirectly82.5K
- William FrazierChief Medical OfficerDirectly73.2K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Michael MoorePresident | 126.3K | 1.59M | Mar 20, 2026 | Form 4 |
| Nitin KaushalDirector | 161.4K | – | Aug 19, 2026 | Form 4 |
| Randy E. DobbsDirector | 142.3K | – | Aug 19, 2026 | Form 4 |
| Timothy SmokoffDirector | 90.5K | – | Aug 19, 2026 | Form 4 |
| Jerome CambreVice President of Sales | 87.5K | – | Aug 13, 2025 | Form 4 |
| Sabrina HeltzDirector | 82.5K | – | Aug 19, 2026 | Form 4 |
| William FrazierChief Medical Officer | 73.2K | – | Jun 25, 2026 | Form 4 |
A lower bound: it counts only the 7 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.09%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.02%
- IWMiShares Russell 2000 ETFWeight in the fund0.01%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.01%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- IWViShares Russell 3000 ETFWeight in the fund0.00%
- DFICDimensional International Core Equity 2 ETFWeight in the fund0.00%
- DFAXDimensional World ex. U.S. Core Equity 2 ETFWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
9 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 131
- Q4 2025: Managers 132
- Q1 2026: Managers 151
- Q2 2026: Managers 167
Institutional investors by quarter
The fund managers holding VMD, quarter by quarter, from Q1 2018 to Q2 2025, 27 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 167 managers held 27.17M shares, worth $310M. During the quarter 29 opened a position, 13 closed one, 68 added and 33 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter+3.6%
- Forager Capital ManagementIn the quarter-24%
- Vanguard Capital ManagementIn the quarter+1.4%
- Nantahala Capital ManagementIn the quarter+43%
- Goldman Sachs GroupIn the quarter-14%
- First Eagle Investment ManagementIn the quarter+102%
- Ameriprise FinancialIn the quarter+12%
- Geode Capital ManagementIn the quarter+25%
- Raffles AssociatesIn the quarter+95%
- Arrowstreet Capital, Limited PartnershipIn the quarter+11%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 4.79M | +3.6% | $55M |
| Forager Capital Management | 2.14M | -24% | $24M |
| Vanguard Capital Management | 1.32M | +1.4% | $15M |
| Nantahala Capital Management | 1.26M | +43% | $14M |
| Goldman Sachs Group | 1.22M | -14% | $14M |
| First Eagle Investment Management | 1.07M | +102% | $12M |
| Ameriprise Financial | 1.01M | +12% | $11M |
| Geode Capital Management | 973.7K | +25% | $11M |
| Raffles Associates | 807.4K | +95% | $9.2M |
| Arrowstreet Capital, Limited Partnership | 786.3K | +11% | $9.0M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Viemed Healthcare's filings show?
Who buys and sells is one part of Viemed Healthcare's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have VMD's insiders bought or sold?
From Jun 26, 2026 to Aug 19, 2026 Viemed Healthcare's insiders bought 0 and sold $347.2K of shares on the market. 0% of the sales were under set 10b5-1 plans.
Which well-known managers hold VMD?
5 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $4.2M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.